Filing Details

Accession Number:
0000899243-20-005808
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-25 18:24:58
Reporting Period:
2020-02-21
Accepted Time:
2020-02-25 18:24:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492674 T2 Biosystems Inc. TTOO Surgical & Medical Instruments & Apparatus (3841) 204827488
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1734339 Alec Barclay 101 Hartwell Avenue
Lexington MA 02421
Svp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-21 10,000 $0.00 52,102 No 4 M Direct
Common Stock Disposition 2020-02-24 5,808 $0.82 46,294 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2020-02-21 10,000 $0.00 10,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2018.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $0.80 to $0.87. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.